Expected next investor conference call information:
Conference Call Date: 10/30/2008
Conference Call Time: 4:45 PM
Conference Call URL: http://ir.millipore.com/phoenix.zhtml?c=96824&p=irol-calendar

Expected next investor conference call information:
Conference Call Date: 10/30/2008
Conference Call Time: 4:45 PM
Conference Call URL: http://ir.millipore.com/phoenix.zhtml?c=96824&p=irol-calendar

Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,000 employees in 47 countries worldwide. For more information, please contact Millipore Tech Service at 1-800-548-7853 or 951-676-8080 or visit www.millipore.com.

ADVANCING LIFE SCIENCE TOGETHER(TM)

Research. Development. Production.

The "M" logo, ADVANCING LIFE SCIENCE TOGETHER and MicroSafe are trademarks of Millipore Corporation.

SOURCE: Millipore Corporation

Millipore Investor Contact: 
Millipore Corporation 
Joshua Young, 978-715-1527 
Director, Investor Relations 
joshua_young@millipore.com

"Millipore is celebrating 20 years in Cork. By simultaneously opening this new facility, we are illustrating our strong commitment to continue our work in Ireland," said Madaus. "Since 1988, our Cork operation has grown from the ground up into a Millipore Manufacturing Center of Excellence employing more than 580 people. We are very proud of our strong track record in process manufacturing."

The new $83 million dollar membrane casting facility is expected to produce a majority of the company's membrane. As a core technology, these membranes are used in a wide range of Millipore products requiring precise filtration and purification.

Millipore's products are used to sterilize drug solutions, test beverages for purity, filter IV fluids in patient care and to support hundreds of other applications in industry sectors including Medical Devices, Pharmaceutical and Biotechnology.

"Millipore is a superb example of how a global company can capitalize on the best that Ireland offers international investors," said Ireland's Minister for Foreign Affairs Micheal Martin. "It employs and nurtures the best people, and benefits from the close co-operation and support offered by IDA Ireland. I congratulate the management teams and workforces over the past 20 years whose dedication and commitment has resulted in the successes we are celebrating today."

About Millipore

Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,000 employees in 47 countries worldwide. For more information, visit www.millipore.com.

SOURCE: Millipore Corporation

Media: 
Millipore Corporation 
Karen Marinella Hall, 978-715-1567 
Director, Corporate Communications 
karen_hall@millipore.com 
or 
Investors: 
Millipore Corporation 
Joshua Young, 978-715-1527 
Director, Investor Relations 
joshua_young@millipore.com